Patents Assigned to SN BIOSCIENCE INC.
  • Patent number: 11793803
    Abstract: A drug delivery system having an inner core-shell like structure containing a poorly soluble camptothecin compound and a water-soluble camptothecin compound, and an outer amphiphilic polymer shell surrounding the inner core-shell like structure, a manufacturing method therefor, and uses of the drug delivery system in treating cancer are disclosed. The core-shell structured particles form very stable particles and show a mono-distribution of particles before and after freeze-drying. The particles show excellent results compared with existing particles which do not contain the inner core-shell like structure, in animal efficacy tests and pharmacokinetic tests.
    Type: Grant
    Filed: April 16, 2021
    Date of Patent: October 24, 2023
    Assignee: SN BIOSCIENCE INC.
    Inventors: Young Hwan Park, Il Hyun Lee
  • Patent number: 11793804
    Abstract: A drug delivery system having an inner core-shell like structure containing a poorly soluble camptothecin compound and a water-soluble camptothecin compound, and an outer amphiphilic polymer shell surrounding the inner core-shell like structure, a manufacturing method therefor, and uses of the drug delivery system in treating cancer are disclosed. The core-shell structured particles form very stable particles and show a mono-distribution of particles before and after freeze-drying. The particles show excellent results compared with existing particles which do not contain the inner core-shell like structure, in animal efficacy tests and pharmacokinetic tests.
    Type: Grant
    Filed: April 16, 2021
    Date of Patent: October 24, 2023
    Assignee: SN BIOSCIENCE INC.
    Inventors: Young Hwan Park, Il Hyun Lee
  • Publication number: 20210308122
    Abstract: A a drug delivery system having an inner core-shell like structure containing a poorly soluble camptothecin compound and a water-soluble camptothecin compound, and an outer amphiphilic polymer shell surrounding the inner core-shell like structure, a manufacturing method therefor, and uses of the drug delivery system in treating cancer are disclosed. The core-shell structured particles form very stable particles and show a mono-distribution of particles before and after freeze-drying. The particles show excellent results compared with existing particles which do not contain the inner core-shell like structure, in animal efficacy tests and pharmacokinetic tests.
    Type: Application
    Filed: April 16, 2021
    Publication date: October 7, 2021
    Applicant: SN BIOSCIENCE INC.
    Inventors: Young Hwan Park, Il Hyun Lee
  • Publication number: 20210236480
    Abstract: A a drug delivery system having an inner core-shell like structure containing a poorly soluble camptothecin compound and a water-soluble camptothecin compound, and an outer amphiphilic polymer shell surrounding the inner core-shell like structure, a manufacturing method therefor, and uses of the drug delivery system in treating cancer are disclosed. The core-shell structured particles form very stable particles and show a mono-distribution of particles before and after freeze-drying. The particles show excellent results compared with existing particles which do not contain the inner core-shell like structure, in animal efficacy tests and pharmacokinetic tests.
    Type: Application
    Filed: April 16, 2021
    Publication date: August 5, 2021
    Applicant: SN BIOSCIENCE INC.
    Inventors: Young Hwan PARK, Il Hyun LEE
  • Publication number: 20210228568
    Abstract: A a drug delivery system having an inner core-shell like structure containing a poorly soluble camptothecin compound and a water-soluble camptothecin compound, and an outer amphiphilic polymer shell surrounding the inner core-shell like structure, a manufacturing method therefor, and uses of the drug delivery system in treating cancer are disclosed. The core-shell structured particles form very stable particles and show a mono-distribution of particles before and after freeze-drying. The particles show excellent results compared with existing particles which do not contain the inner core-shell like structure, in animal efficacy tests and pharmacokinetic tests.
    Type: Application
    Filed: April 16, 2021
    Publication date: July 29, 2021
    Applicant: SN BIOSCIENCE INC.
    Inventors: Young Hwan PARK, ll Hyun Lee
  • Publication number: 20210228569
    Abstract: A a drug delivery system having an inner core-shell like structure containing a poorly soluble camptothecin compound and a water-soluble camptothecin compound, and an outer amphiphilic polymer shell surrounding the inner core-shell like structure, a manufacturing method therefor, and uses of the drug delivery system in treating cancer are disclosed. The core-shell structured particles form very stable particles and show a mono-distribution of particles before and after freeze-drying. The particles show excellent results compared with existing particles which do not contain the inner core-shell like structure, in animal efficacy tests and pharmacokinetic tests.
    Type: Application
    Filed: April 16, 2021
    Publication date: July 29, 2021
    Applicant: SN BIOSCIENCE INC.
    Inventors: Young Hwan PARK, Il Hyun Lee
  • Patent number: 10980796
    Abstract: The present invention relates to a drug delivery system having a double core-shell structure and, specifically, to a double nano-drug delivery system having an inner core-shell containing a poorly soluble camptothecin compound and a water-soluble camptothecin compound inside and an amphiphilic polymer shell, and to a manufacturing method therefor. The double core-shell structured particles manufactured by the present invention form very stable particles and show a mono-distribution of particles before and after freeze-drying. The particles of the present invention show excellent results compared with existing monolayer micelles in animal efficacy tests and pharmacokinetic tests, and do not use a surfactant causing hypersensitivity, and thus the use of the particles of the present invention can provide a pharmaceutical composition or a drug delivery system platform, which are safe for the human body.
    Type: Grant
    Filed: June 22, 2018
    Date of Patent: April 20, 2021
    Assignee: SN BIOSCIENCE INC.
    Inventors: Young Hwan Park, Il Hyun Lee